Pharma Exports Once Again Decline In January; Grows Marginally For 10 Month Period

New Delhi : Exports of pharmaceuticals have once again reported a decline in the month of January, 2022 in comparison with the corresponding period of previous fiscal year. The cumulative exports for the 10 months from April, 2021, however, touched the $20 billion figure and showed a marginal growth, as against the same period of last year, according to the data released by the ministry of commerce and industry.

For the month of January, exports of drugs and pharmaceuticals declined 1.15 per cent to $2.05 billion as compared to $2.08 billion registered in the same month of 2021. Exports for the ten months ended January, 2022, has grown 0.44 per cent to $20.24 billion as compared to $20.15 billion reported in the same period of last fiscal year.

The decrease in exports comes after the sector turned back to growth in December, 2021, with a growth of 5.2 per cent to $2.32 billion as compared to $2.2 billion in the same month of previous year.

The three consecutive months before that has reported a decline in exports, owing to various trends including multifold increase in freight rates and a decline in exports to the US, among others. Exports of drugs and pharmaceuticals have registered a decline in the three consecutive months from September, October and November, with exports declining 8.45 per cent, 0.88 per cent and 7.03 per cent respectively, compared to the corresponding months of the previous year.

Following the decline in sales, the industry experts have said that it may miss the target of $29 billion set by the government earlier. They said that an achievable target could be a growth similar to last year, to around $26 billion, given the current trend. The year 2020-21 saw an exceptional growth of 18.19 per cent in exports, to $24.4 billion, which is the level of growth that happened after eight years.

Imports of medicinal and pharmaceutical products registered a 27.35 per cent growth in January, 2022, to $700.85 million, as compared to $550.32 million during the corresponding period of last fiscal year. The ten months growth of imports in the sector is 31.29 per cent to $7.61 billion as against an imports of $5.8 billion during the April 2020 to January 2021 period, according to the quick estimates for major commodities for the month of January, 2022, released by the ministry of commerce and industry.

Pharmaceutical exports have registered growth in the last few years, following a 2.92 per cent growth it registered for the year 2017-18, at $17.28 billion. The year 2018-19 has seen a growth of 10.72 per cent to $19.13 billion compared to the previous year, 2019-20 with a growth of 7.57 per cent to $20.58 billion, before hitting an eight year high or 18.19 per cent growth to $24.47 billion in the year 2020-21.

  • Related Posts

    Annovis Bio receives US patent covering new crystalline form of buntanetap

    Annovis Bio, Inc. (Annovis), a phase 3 clinical-stage biotechnology company developing the investigational oral therapy, buntanetap, for neurodegenerative diseases such as Alzheimer’s disease (AD) and Parkinson’s disease (PD), announced that…

    Bengaluru: Medical devices worth ₹13.79 lakh seized in enforcement drive

    The enforcement wing of Karnataka’s Food Safety and Drugs Control Department has seized medical devices and consumables worth ₹13.79 lakh from two establishments in Bengaluru’s Cottonpet area for alleged violations…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Annovis Bio receives US patent covering new crystalline form of buntanetap

    Annovis Bio receives US patent covering new crystalline form of buntanetap

    Bengaluru: Medical devices worth ₹13.79 lakh seized in enforcement drive

    Bengaluru: Medical devices worth ₹13.79 lakh seized in enforcement drive

    Yashoda Medicity Unveils T-Shirts & Finisher Medals ahead of Yashoda Half Marathon 4.0

    Yashoda Medicity Unveils T-Shirts & Finisher Medals ahead of Yashoda Half Marathon 4.0

    PharmEasy sees need for early prevention and regular screening to stall risk of diabetes

    PharmEasy sees need for early prevention and regular screening to stall risk of diabetes

    Saudi pharma company seeks Indian manufacturers for product registration, commercialisation in Saudi Arabia

    Saudi pharma company seeks Indian manufacturers for product registration, commercialisation in Saudi Arabia

    From ‘Kidney Care’ to ‘Liver Detox’, Uttar Pradesh bans misleading supplement labels

    From ‘Kidney Care’ to ‘Liver Detox’, Uttar Pradesh bans misleading supplement labels